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Abstract
Background: Adverse events are considered a major international problem related to the performance of health
systems. Evaluating the occurrence of adverse events involves, as any other outcome measure, determining the
extent to which the observed differences can be attributed to the patient’s risk factors or to variations in the
treatment process, and this in turn highlights the importance of measuring differences in the severity of the cases.
The current study aims to evaluate the association between deaths and adverse events, adjusted according to
patient risk factors.
Methods: The study is based on a random sample of 1103 patient charts from hospitalizations in the year 2003 in
3 teaching hospitals in the state of Rio de Janeiro, Brazil. The methodology involved a retrospective review of
patient charts in two stages - screening phase and evaluation phase. Logistic regression was used to evaluate the
relationship between hospital deaths and adverse events.
Results: The overall mortality rate was 8.5%, while the rate related to the occurrence of an adverse event was 2.9%
(32/1103) and that related to preventable adverse events was 2.3% (25/1103). Among the 94 deaths analyzed, 34%
were related to cases involving adverse events, and 26.6% of deaths occurred in cases whose adverse events were
considered preventable. The models tested showed good discriminatory capacity. The unadjusted odds ratio (OR
11.43) and the odds ratio adjusted for patient risk factors (OR 8.23) between death and preventable adverse event
were high.
Conclusions: Despite discussions in the literature regarding the limitations of evaluating preventable adverse
events based on peer review, the results presented here emphasize that adverse events are not only prevalent, but
are associated with serious harm and even death. These results also highlight the importance of risk adjustment
and multivariate models in the study of adverse events.
Background
The occurrence of adverse events is considered a serious
problem worldwide regarding the performance of health
services [1]. A report by the United States Institute of
Medicine called attention to the fact that the mortality
rate due to adverse events was higher than that attribu-
ted to some of the principal causes of mortality, such as
motor vehicle accidents, breast cancer, and AIDS [2].
Studies have indicated that approximately 10% of the
incidence of adverse events are related to hospital care,
and it is estimated that 4.4% to 20.8% of adverse events
lead to patient death [3,4].
The concept of adverse event is related to the occur-
rence of harm or injury caused by medical care rather
than by the underlying disease [5]. Thus, assessing the
occurrence of an adverse event involves distinguishing
between undesirable results caused by problems in the
quality of care and those resulting from the patient’s
inherent risk factors and the severity of the case, which
define the prognosis and odds of survival [6,7]. A central
concern in evaluating the outcomes of health care, espe-
cially regarding adverse events or hospital deaths, is the
identification of preventable cases [8].
Sox et al [9] contrast the Institute of Medicine’se s t i -
mate of deaths of hospitalized patients resulting from
medical error [2] with the robustness of the methods
used in this calculation. Their central argument is that
the methodology involves peer review, characterized by
a high degree of subjectivity in the assessment and low
inter-reviewer reliability [8].
* Correspondence: martins@ensp.fiocruz.br
1Departamento de Administração e Planejamento em Saúde - Escola
Nacional de Saúde Pública Sérgio rouca. Fundação Oswaldo Cruz. Rio de
Janeiro, RJ, Brazil
Full list of author information is available at the end of the article
Martins et al. BMC Health Services Research 2011, 11:223
http://www.biomedcentral.com/1472-6963/11/223
© 2011 Martins et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.Few studies were carried out with the particular pur-
pose of identifying an association between hospital
deaths and adverse events [3,4,10,11]. Generally, studies
have focused on evaluating specific situations such as
surgical cases and hospital infections [10,12,13]. Garcia-
Martin et al [11] developed a case-control study to esti-
mate the proportion of hospital deaths associated with
adverse events. They found that the presence of at least
one adverse event was significantly associated with an
increased risk of death (OR = 1.75), and that 24% of
deaths were associated with adverse events. A study car-
ried out in the Netherlands [3] examined adverse events
and preventable deaths using a specific sample of cases
of death and found that, among the patients who died,
10.7% had suffered an adverse event, while preventable
adverse events accounted for 4.1% of hospital deaths.
Importantly, Hayward & Hofer [8] point to an overesti-
mation of preventable deaths associated with good-qual-
ity care, since the majority of estimates overlooks the
underlying prognostic factors of patients who died.
Weingart et al [14] further highlight that risk is not
homogeneous. Patients who are more severely ill, are
subject to multiple interventions and remain hospita-
lized longer are more likely to suffer serious injury or
harm as a result of medical error.
Considering the relevance of this theme and the lack
of studies, especially in developing countries, this article
has the objective to evaluate the relationship between
hospital deaths and adverse events, adjusted for patient
risk factors, in hospitalized patients in Brazil.
Methods
Study design and population
The data were obtained from a previous study on the inci-
dence of adverse events in Brazilian hospitals that used
retrospective chart review as the methodology [15,16],
b a s e do nt h ed e s i g na n dt o o l sd e v e l o p e db yC a n a d i a n
researchers. According to the Canadian Adverse Event
Study [17], an adverse event was defined as an unintended
injury which results in temporary or permanent disability,
including increased length of stay caused by clinical care
rather than disease process. Preventability refers to an
adverse event resulting from an error or series of errors,
either negligent or non-negligent, or failure.
Patient charts were reviewed in two stages: (1) screening
of potential adverse events by nurses and (2) identification
of adverse events by physicians. The screening stage was
based on the presence of at least one of 18 previously
established screening criteria (trigger tools). Death was
one of the 18 triggers, so all the deaths were selected for
the second stage. Based on evidence in each patient’s
chart, the second stage of evaluation confirmed (or dis-
proved) the occurrence of an adverse event and its pre-
ventability. Six-point scales were used, and results greater
than or equal to 4 were defined as confirming the presence
of an adverse event and its preventability. The assessment
of preventable adverse events was based on subjective and
implicit criteria, backed by the expertise, practical experi-
ence and clinical decision-making of physicians [18]. The
assumption was that a preventable adverse event results
from poor quality in the process of care or problems in
the health system.
In the present study, 1103 patient charts were selected
by means of simple random sampling out of 27,350 adult
patients admitted between January 1
st, 2003, and Decem-
ber 31
st, 2003, to 3 general teaching hospitals in the state
of Rio de Janeiro, Brazil. Two of the hospitals have emer-
gency departments and maternity wards. The hospitals
were selected based on their voluntary willingness to colla-
borate and the degree of excellence in their areas of
expertise.
Following the Canadian study [17], the exclusion criteria
were patients under 18 years of age, patients who
remained hospitalized for less than 24 hours, and psychia-
tric patients. However, unlike the Canadian study, obste-
tric cases were included in the sample in face of the
persistently high maternal mortality rate in Brazil. The
random sample process was applied to each hospital. The
parameters used to define the sample size were also based
on the Canadian study: a 10% expected incidence of
patients with adverse events (maximum absolute error
-3%), a 50% proportion of potential adverse events, and a
significance level of 5%. The loss rate was estimated at
10%, and the rate of ineligible patients was estimated at
20% [16].
Data analysis
The analysis of the relationship between deaths and
adverse events assumed that patient characteristics asso-
ciated with case severity are important confounding fac-
tors. In order to identify the variables associated with the
risk of death in the study population, we conducted uni-
variate and bivariate analyses using variables related to
demographic and clinical patient characteristics and to the
hospitalization, including type of admission (elective,
urgency, and emergency), specialty (obstetrics versus non-
obstetrics), procedure performed, and length of stay.
Patients’ social variables were not analyzed due to the high
percentage of missing information.
Multiple logistic regression was used to analyze factors
associated with death in the selected cases. The dichoto-
mous dependent variable was death (yes/no). Only deaths
that occurred during the hospital stay were analyzed. The
following steps were applied for modeling: (1) baseline
model; (2) introduction of the variables related to the
process of care: clinical specialty (obstetrics: yes/no),
length of stay (continuous variable), and performance of
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of the occurrence of an adverse event.
The initial baseline model (model 1) was constructed to
adjust for patient risk factors, since the prognosis depends
on patient attributes that indicate the severity of the case.
The baseline model consisted of the following indepen-
dent variables: age, gender, primary diagnosis, secondary
diagnoses (comorbidities), and type of admission. Age was
treated as a categorical variable, where younger than 50
years of age was the reference category, and patients older
than 79 were grouped due to the small number of cases.
Gender, treated as a dichotomous variable, used the male
gender as the reference category. This variable was main-
tained in the model for theoretical reasons, although it has
not shown to be of statistical significance.
The primary diagnosis of patients is an essential dimen-
sion for risk adjustment, but specific reasons for admission
were not considered due to the wide range of diagnostic
categories identified and the low number of cases in each
category. As a strategy to control severity, the Charlson
index [19] was applied to the primary diagnosis. The vari-
able with the Charlson index score for the primary diagno-
sis was treated as a dichotomous variable, where the
reference category was a score equal to 0.
The Charlson index [19] was also applied to the 6
reported secondary diagnoses and was the fourth indepen-
dent variable introduced into the baseline model. This
index was treated as a categorical variable. According to
the frequency distribution, the categories for this index
were regrouped as follows: (1) score 0 (reference category);
(2) score 1; and (3) score greater than or equal to 2. We
used the algorithm developed by Quan et al [20] to trans-
late the clinical conditions from the Charlson index [19]
to the International Classification of Diseases, 10
th Revi-
sion (ICD-10).
Type of admission was the last variable included in the
baseline model, since unplanned admissions (emergen-
cies) generally entail greater risk of death than planned
(elective) admissions [7]. Type of admission was treated
as a dichotomous variable with 2 groups, where elective
admissions constituted the reference category.
Variables related to the process of care - length of stay,
surgical or invasive procedure performed, and specialty -
were also tested (model 2). Length of stay was treated as a
continuous variable. The reference categories for proce-
dures performed and specialty were no procedure per-
formed and obstetrics, respectively. These variables were
subsequently excluded because they lacked statistical
significance.
The occurrence of an adverse event, including its pre-
ventability, was the main independent variable for measur-
ing whether this event represented a risk factor associated
with the worsening of patient prognosis and an adverse
outcome (death). It was included in the third modeling
step (final model). The occurrence of adverse events was
treated as a categorical variable, and the categories were
grouped as follows: (1) no adverse events (reference cate-
gory); (2) no preventable adverse events; and (3) preventa-
ble adverse events. The cases of adverse events are
described in the Additional File 1: Appendix.
We tested the impact of the introduction of each variable
on the model’s performance, starting from the baseline
model. The adequacy of the model for predicting death
was assessed according to the percentage of improvement
in the model as compared to the initial deviance (likelihood
c
2), C statistics, and Hosmer-Lemeshow test. The statistical
analyses were processed with SPSS 17.0. This study was
approved by the Ethics Committee of the Oswaldo Cruz
Foundation, protocol 271/05.
Results
A total of 1103 clinical charts of patients admitted to 3
teaching hospitals in the state of Rio de Janeiro were
reviewed. Most admissions were in non-obstetric special-
ties (80.5%). The mean age was 46.9 years, and 61.3% of
the patients admitted were women (Table 1). The propor-
tions of principal diagnoses grouped according to the
chapters of the ICD-10 revealed that 44.7% of the cases
analyzed were admitted for problems associated with preg-
nancy, childbirth and postpartum, diseases of the circula-
tory system, and diseases of the digestive system. The
proportion of admissions with a secondary diagnosis
recorded in the charts was 54.2%, while in cases of death
this proportion was 87.2% (Table 1). More than 50% of
the cases were emergency admissions; more than 70% of
the cases underwent some procedure. Of the 94 deaths
analyzed, 34% occurred in cases with an adverse event,
and 26.6% of the deaths occurred in cases involving
adverse events classified as preventable (Table 1).
Analysis of the relationship between death and patient
risk factors (age, gender, Charlson index) showed a statis-
tically significant association (Table 2). Except for gender,
the correlations were around 0.20. Type of admission had
a correlation of 0.21 and unadjusted odds ratio of 5.14
(Table 2). Among the variables related to the process of
care (specialty, procedure, and length of stay), only the
type of procedure was not statistically significant.
The overall hospital mortali t yr a t ew a s8 . 5 % ,b u tt h i s
rate increased to 38.1% in the subset of cases with the
occurrence of an adverse event, and to 44.6% in the sub-
set of cases with a preventable adverse event (Table 2).
The correlation between death and adverse event showed
a statistically significant association, with odds ratio of
9.50 (Table 2). There was also a significant association
between death and preventable adverse event, with an
even higher odds ratio (11.43). The mortality rate related
to adverse events was 2.9% (32/1103), while that related
to preventable adverse events was 2.3% (25/1103).
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quence of the adverse event and the severity of the case,
was 25.1 days in cases with a fatal outcome (SD: 33.4;
95% CI: 18.3-32.0 days), more than twice as much as
cases without death (11.1 days - SD: 22.2; 95% CI: 9.7-
12.5 days). A similar pattern emerged when comparing
cases with and without an adverse event: the mean
length of stay tripled in cases with adverse events (32.4
days - SD: 36.0; 95% CI: 24.6-40.2 days) compared to
those without adverse events (10.6 days - SD: 21.5; 95%
CI: 9.3-12.0 days).
None of the tested models showed any adjustment pro-
blems, as confirmed by the Hosmer-Lemeshow test
(Table 3). The three models presented good predictive
capacity, as measured by the C statistic (Table 3). The
introduction of the variable related to the occurrence of
an adverse event impacted the model’s performance.
Among the variables related to the process of care, length
of stay was the only one statistically significant, but it did
not impact the baseline model’s discriminatory capacity
(Table 3; model 2). In the second modeling step, the
introduction of the clinical specialty variable (obstetrics,
yes/no) was not statistically significant, besides slightly
decreasing the model’s predictive capacity (C statistic =
0.84; 95% CI 0.80-0.88).
With the exception of gender, the odds ratios for the
other variables were greater than 1.5. The application of
the Charlson index to the primary diagnosis yielded an
odds ratio of 2.41 for cases with score greater than or
e q u a lt o1 ,a sc o m p a r e dt os c o r ee q u a lt o0 .T h i si n d e x
also displayed an upward gradient when applied to
comorbidities (Table 4, baseline model). Age greater than
79 years (OR: 8.18) and unplanned admissions had the
highest odds ratios in the baseline model (Table 4). In
t h eb a s e l i n ea n df i n a lm o d e l s ,s c o r e1i nt h eC h a r l s o n
index applied to comorbidities was not statistically signif-
icant (Table 4). In the final model, risk of death adjusted
by case severity was high in patients with non-preventa-
ble adverse events (OR 6.23), compared to patients with-
out any adverse event. However, patients with an adverse
event classified as preventable showed an even higher
odds ratio (8.23) (Table 4). Regarding patient risk vari-
ables in the final model, after the occurrence of adverse
events was included, the odds ratio for elderly patients
(> 79 years) presented the biggest decrease. For the other
variables the odds ratio remained quite similar, being
slightly lower for patients between 50 and 59 years old
(Table 4).
Discussion
The occurrence of adverse events was examined as a fac-
tor associated with risk of death adjusted by case severity.
The overall mortality rate in the study population was
8.5%; 2.9% had adverse events and 2.3% had preventable
adverse events. The logistic regression models tested in
order to evaluate the relationship between hospital death
and adverse event, adjusted according to patient risk,
showed good discrimination capacity [21]. The unad-
justed odds ratio between death and preventable adverse
Table 1 Study population characteristics: sampled
admissions and deaths
Characteristics Sampled cases Deaths
Number of cases (% of total) 1103 (100.0) 94 (8.5)
Demographics
Age (years)
Mean age in years (SD) 46.9 (19.1) 61.9 (16.7)
Median 46 65
Mode (Range) 25 (18-92) 71 (20-92)
Age bracket (%)
18-49 56.4 21.3
50-59 14.0 18.1
60-69 13.9 23.4
70-79 11.1 23.4
80-99 4.6 13.8
Women (%) 61.3 47.9
Comorbidity
Record of 1 secondary diagnosis (%) 54.2 87.2
Record of 2 secondary diagnoses (%) 33.0 75.5
Record of 6 secondary diagnoses (%) 2.5 8.5
Charlson index (% by score)
Primary diagnosis
0 82.0 57.4
1 18.0 42.6
Secondary diagnoses
0 75.1 46.8
1 13.2 24.5
≥ 2 11.7 28.7
Type of admission (%)
Elective 44.6 14.9
Urgency/Emergency 55.4 85.1
Specialty (%)
Obstetrics 19.5 0
Non-obstetrics 80.5 100.0
Procedure performed (%) 77.5 72.3
Length of stay (days)
Mean (SD) 12.8 (23.6) 25.2 (33.4)
Median 5.0 16.5
Mode 2.0 7.0*
Range 1-408 1-236
Adverse event
Number of patients (% of total) 84 (7.6) 32 (34.0)**
Preventable adverse event
Number of patients (% of total) 56 (5.1) 25 (26.6) **
Non-preventable adverse event
Number of patients (% of total) 28 (2.5) 7 (7.5) **
* There is more than one value considered as the mode.
** Proportional mortality.
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adjusted for patient risk factors decreased to 8.23, but
remained high. The relationship between death and non-
preventable adverse event, i.e. complications due to the
complexity of the case, showed an even high adjusted
odds ratio (OR 6.25).
More than ten years ago, Hayward & Hofer [8,22]
highlighted the fact that estimates on the relationship
between death and adverse event failed to consider
patient risk factors in the analysis. In the present study,
using logistic regression for risk adjustment, it can be
seen that older patients have higher odds of dying. How-
ever, it appears that part of this risk is related to the
occurrence of adverse events. This point demonstrates
the difficulty of isolating the effect of each factor. It
s e e m st h a tt h i sk i n do fa s s o c i a t i o ni sm u c hm o r e
Table 2 Measures of association between death and patient characteristics, process of care, preventable and non-
preventable adverse events
Independent variables Number of cases
(A)
Number of deaths
(B)
% Deaths
(B/A*100)
Measure of association
Gender
Male* 427 49 11.5 OR 0.55 (95% CI: 0.36-0.84)
Female 676 45 6.7 (p < 0.005)
R = -0.08
Age bracket
18-49* 622 20 3.2
50-59 155 17 11.0 c2 63.380; 4 df, p < 0.000
60-69 153 22 14.4 Somers’ D 0.11, p < 0.000
70-79 122 22 18.0 R = 0.24
80-99 51 13 25.5
Charlson index (score)
Primary diagnosis
0* 904 54 6.0 OR 3.96 (95% CI: 2.54-6.16)
1 199 40 20.1 (p < 0.000)
R = 0.20
Secondary diagnosis
0* 828 44 5.3 c2 46.200; 2 df, p < 0.000
1 146 23 15.8 Somers’ D 0,12, p < 0.000
≥ 2 129 27 20.9 R = 0.20
Type of admission
Elective* 492 14 2.8 OR 5.14 (95% CI: 02.89-9.20)
Urgency/Emergency 611 80 13.1 (p < 0.000)
R = 0.18
Specialty
Obstetrics* 215 0 0.0 OR 0.79 (95% CI: 0.76-0.81)
Non-obstetrics 888 94 10.6 p < 0.000
R = 0.15
Procedures performed**
No* 248 26 10.5 OR 0.74 (95% CI: 0.46-1.19)
Yes 855 68 8.0 (p > 0.209)
R = -0.04
Adverse event*
No * 1019 62 6.1 OR 9.50 (95% CI: 5.71-15.82) (p < 0.000)
Yes 84 32 38.1 R = 0.30
Preventable adverse event
No* 1047 69 6.6 OR 11.43 (95% CI: 6.40-20.43) (p < 0.000)
Yes 56 25 44.6 R = 0.30
Total 1103 94 8.5
Dependent variable: death.
OR: Odds ratio; R: Pearson correlation.
* Reference categories for odds ratios.
** Included surgical and invasive procedure.
Martins et al. BMC Health Services Research 2011, 11:223
http://www.biomedcentral.com/1472-6963/11/223
Page 5 of 8synergic and involves patient risk factors, the process of
care, non-preventable complications, and even preventa-
ble adverse events. Nevertheless, 50-59 year-old patients
in our study presented a slight increase in death risk
after the occurrence of adverse events was included.
Despite discussions in the literature on the methodo-
logical limitations of the evaluation of preventable
adverse events based on peer review [8,10,22,23], the
findings presented here emphasize not only that adverse
events are prevalent but that preventable adverse events
are associated with serious and irreversible harm, and
even death. Notwithstanding differences in the study
design, the adjusted odds ratio obtained here was much
higher than that described by Garcia-Martin et al [11],
who reported 1.75. According to Zegers et al [3], 10.7%
of deaths among patients in the Netherlands were asso-
ciated with an adverse event, while in our study this
proportion was much higher (34%). In our study, cases
involving preventable adverse events accounted for
2 6 . 6 %o ft h ed e a t h s ,w h i l ei nt h eD u t c hs t u d yt h ep r o -
portion was only 4.1% of hospital deaths [3]. These find-
ings indicate an increased risk of serious adverse events
among Brazilian patients.
Principal study limitations
It is important to acknowledge that the findings may be
related to the characteristics of the study design and the
study population. Importantly, the study population was
limited to admissions to 3 public teaching hospitals in a
single state of Brazil, which could partially explain the
results. Hospital characteristics minimize the generaliza-
tion capacity of the study. Brazil has more than 5,000
hospitals; they are heterogeneous in terms of facilities,
human resources, and quality of care. Since the selected
hospitals have adequate medical records and develop
training activities, among others factors, the results pre-
sented are probably better in these hospitals than in
many others. Therefore, we consider that the numbers
obtained could be underestimated for the Brazilian
reality.
Primary diagnosis is an important dimension of case
severity and a determinant in the process and quality of
care, and thus is correlated with the occurrence of
adverse events and deaths [3]. Because of the low num-
ber of cases in specific diagnostic categories, we opted
to apply the Charlson index [19], without the respective
weights, as indicative of the severity associated with the
principal reason for admission. Despite the difficulty of
interpreting the relationship between length of stay and
death, case severity, and characteristics of the health ser-
vice system [24], the length of stay variable, expressing
severity and characteristics of the process of care,
remained in the final model.
Conclusion
In the context of health care, the evaluation of any out-
come measure involves determining the extent to which
the observed differences can be attributed to patient risk
factors or to the various treatment processes [7]. This
highlights the importance of measuring differences in
the severity of cases in studies about adverse events.
Despite some limitations in the study design and ana-
lytical strategy, we observed a correlation between the
occurrence of adverse events and the risk of hospital
death; this association was higher when the preventabil-
ity of the adverse event was considered. However, the
vast majority of preventable events with fatal outcomes
occurred in cases classified as level 4 in the judgment
scale, and very few cases (4/25 deaths) were classified as
levels with greater certainty. This point corroborates the
limitations identified by Hayward & Hofer [8], i.e., that
studies based on peer review are characterized by a high
degree of subjectivity in the judgment of the reviewers.
Even so, we feel that the current study, which includes
the use of risk adjustment and multivariate models,
represents an important step in the evaluation of the
occurrence of adverse events. Its future developments
can contribute to specific interventions and to further
studies focused on improving clinical performance in
hospitals [25,26], particularly considering the issue of
Table 3 Discriminatory capacity and adjustment of models for predicting death
Model c
2 of Model* Hosmer-Lemeshow c
2 test C Statistic
(95% CI)
1. Baseline model**: 137.236
(df 9, sig. 0.000)
13.898
(sig. 0.053)
0.85
(0.82-0.89)
2. Baseline model + Length of stay*** 148.015
(df 10, sig. 0.000)
13.638
(sig. 0.092)
0.85
(0.82-0.89)
3. Final model: Model 2 + Occurrence of adverse event **** 187.316
(df 12, sig. 0.000)
11.271
(sig. 0.187)
0.88
(0.85-0.91)
* Initial likelihood c
2 with intercept: 484.387 (Wald).
** Baseline model includes: gender, age, Charlson index applied to primary and secondary diagnoses, and type of admission.
*** Surgical or invasive procedure and clinical specialty variables were also tested, but were excluded due to lack of statistical significance.
**** Occurrence of adverse event = no, yes non-preventable, yes preventable.
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national healthcare agenda.
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Table 4 Logistic regression for prediction of hospital death: baseline model and final model
Baseline model b p-value Odds ratio 95% CI
Female gender -0.572 0.018 0.56 0.35 0.91
Age bracket (years)
18-49* 0.000
50-59 0.961 0.011 2.61 1.25 5.47
60-69 1.359 0.000 3.89 1.93 7.85
70-79 1.388 0.000 4.01 1.97 8.13
80-99 2.102 0.000 8.18 3.54 18.90
Primary diagnosis (Charlson index ≥ 1) 0.879 0.000 2.41 1.47 3.94
Secondary diagnoses (Charlson index)
0* 0.009
1 0.476 0.122 1.61 0.88 2.95
2 0.895 0.002 2.45 1.37 4.36
Urgency and emergency admissions 1.750 0.000 5.76 3.12 10.61
Constant -4.603 0.000 0.01
Final Model b p-value Odds ratio 95% CI
Female gender -0.662 0.011 0.52 0.31 0.86
Age bracket (years)
18-49* 0.000
50-59 0.993 0.010 2.70 1.26 5.77
60-69 1.115 0.003 3.05 1.45 6.40
70-79 1.178 0.002 3.25 1.53 6.88
80-99 1.879 0.000 6.55 2.63 16.32
Primary diagnosis (Charlson index ≥ 1) 0.859 0.001 2.36 1.40 3.98
Secondary diagnoses (Charlson index)
0* 0.013
1 0.523 0.107 1.69 0.89 3.18
2 0.893 0.004 2.44 1.33 4.49
Urgency and emergency admissions 1.788 0.000 5.98 3.14 11.39
Length of stay 0.008 0.044 1.01 1.00 1.02
Occurrence of adverse event
No*
Yes, non-preventable 1.832 0.001 6.25 2.21 17.70
Yes, preventable 2.108 0.000 8.23 4.02 16.82
Constant -4.957 0.000 0.01
* Reference categories
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